ABSTRACT We have found that hypertonic medium inhibited the receptor-mediated uptake of the chemotactic peptide N-formylnorleucylleucylphenylalanine without affecting fluidphase endocytosis by polymorphonuclear leukocytes (PMNs). Morphological and biochemical evidence demonstrated that cells in hypertonic medium did not accumulate peptide in a receptor-mediated manner. However, the cells continued to form endosomes containing fluidphase markers. Furthermore, the content of these endosomes was processed normally, i.e., both digested and intact material were released into the medium. The inhibition of receptormediated uptake was a function of the tonicity. Partial inhibition occurred in 0.45 and 0.6 osmolar medium and maximal inhibition occurred in 0.75 osmolar medium. The inhibition was independent of the solute used to increase the tonicity: sodium chloride, sucrose, and lactose all inhibited uptake to similar extents. Hypertonic medium had little effect on saturable peptide binding. However, it did prevent the clustering of surface molecules as indicated by the inhibition of capping of fluorescent concanavalin A. In addition, hypertonic medium prevented the peptide-stimulated increase in cytosolic calcium levels as measured by quin 2 fluorescence. The tonicity dependence of the inhibition of quin 2 fluorescence paralleled the inhibition of receptor-mediated uptake.
One approach to examining the question of the uptake and subsequent fate of fluid markers and specific ligands is to develop conditions which selectively alter one or the other endocytic pathway. However, treatments which reduce the receptor-mediated accumulation of ligand often produce a decrease in fluid-phase endocytosis (5, 6) . We now report that hypertonic medium selectively inhibits receptor-mediated uptake without affecting fluid-phase endocytosis. Our studies show that in polymorphonuclear leukocytes (PMNs), l the receptor-mediated accumulation of the chemotactic peptide N-formylnorleucylleucylphenylalanine (f-NleLeuPhe) is inhibited by 0.75 osmolar medium, while fluid-phase endocytosis is not affected. Endosomes containing fluid-phase markAbbreviations used in this paper: Con A, concanavalin A; FITC, fluorescein isothiocyanate; f-NleLeuPhe, N-formylnorleucylleucylphenylalanine; HBSS, Hanks' balanced salt solution; hexapeptide, N-formyl-NleLeuPheNleTyrLys; hNaCi, HBSS plus 0.225 M NaC1; hsucrose, HBSS plus 0.45 M sucrose; Hy, hemocyanin;/~, dissociation constant; PMN, polymorphonuclear leukocytes; RBCs, erythrocytes; TCA, trichloroacetic acid; TMR, tetramethylrhodamine isothiocyanate. ers continue to form and deliver these markers to intracellular compartments where digestion occurs. This inhibition is not due to an effect on the binding of peptide to its receptor. In addition, we show that 0.75 osmolar medium completely prevents the peptide-stimulated increase in cytosolic calcium levels as measured by the fluorescent probe, quin 2. The inhibition of the peptide stimulation ofquin 2 shows a similar dependence on the tonicity as the inhibition of receptormediated uptake with maximal inhibition occurring in 0.75 osmolar medium.
MATERIALS AND METHODS

Cells:
Rabbit peritoneal exudate PMNs were collected 4 h after injection of 0.1 g of shellfish glycogen (Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, NY) in 250 ml of 0.9% saline. Contaminating erythrocytes (RBCs), if present, were lysed by a brief(60-s) treatment with hypotonic (0.18%) saline. The cells were washed twice with 0.9% saline and resuspended in Hanks' balanced salt solution (HBSS) (Gibco Laboratories, Grand Island, NY) buffered with 2.4 mg/ml of HEPES (Sigma Chemicai Co., St. Louis, MO) at a concentration of 3.3 x l06 cells/ml. 3 ml of the cell suspension was placed in 60 x 15-ram petri dishes (Falcon Labware, Becton, Dickinson & Co., Oxnard, CA) and the cells were allowed to settle for 15 min at 23"C. Dishes were checked with an inverted microscope to ensure that an even monolayer had formed.
Human PMNs were obtained from blood by venipuncture. The blood was mixed with 0.6% dextran 70 and 0.02 M sodium citrate in saline (final concentrations). The RBCs were allowed to settle, the plasma layer was removed, and the cells were pelleted at 400 g for l0 rain. Contaminating RBCs were lysed by exposure to 0.18% saline for 30 s. Cells were washed and resuspended in Ca ++-and Mg++-free HBSS, layered on Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ), and spun 20 min at 600 g. The cell pellet was resuspended and washed twice in HBSS without phenol red.
Media:
The tonicity of the media was adjusted to the final desired osmolarity by the addition of the appropriate amount of sucrose, lactose, or sodium chloride. Cells were pretreated for l0 min at 37"C with the hypertonic medium prior to the start of an experiment.
Peptide Uptake and Release: Cells were incubated for varying times with [3H]f-NleLeuPhe (New England Nuclear, Boston, MA; specific activity I I Ci/mM) at 37"C and then washed for 10 rain at 4"C. This has previously been shown to remove >95% of the receptor-bound peptide (13) . The peptide remaining cell associated after this wash is the "total uptake."
By varying the concentration of peptide, we could follow either receptormediated or fluid-phase uptake. Rabbit peritoneal PMNs have a receptor for fNleLeuPhe which has a dissociation constant, Kd, of about 2 x l0 -s M. From a dose-response curve of f-NleLeuPhe uptake, we have determined the percentage of the total uptake which occurred via a receptor-mediated process at each concentration of peptide (2) . Both total uptake and nonsaturable uptake (3H-peptide uptake in the presence of an excess of unlabeled peptide [l,000 times the K~ concentration]) were measured. Receptor-mediated uptake was calculated by subtracting nonsaturable uptake from total uptake. At concentrations of peptide <3 x l0 -8 M, the majority of the uptake is via a receptormediated process, specifically, at 2 x l0 -s M, 80% of the uptake occurs in a saturable manner. The accumulation of peptide at concentrations above ~3 x l0 -s M is proportional to the concentration of peptide present in the extracellular medium. At these high concentrations, peptide acts as a fluid-phase marker. At 10 -s peptide, only 1% of the counts accumulated could be accounted for by a saturable process. These experimentally derived values are consistent with the following calculation which estimates the proportion of total uptake of peptide that occurs in the fluid-phase when cells are incubated with l0 -s M f-NleLeuPhe. At l0 -s M f-NleLeuPhe (l,000 times the K,s concentration), all of the receptors should be occupied, i.e., approximately two times the number occupied at 2 x l0 -8 M (/~). Therefore, the amount of peptide taken up in receptor-mediated manner would be expected to be twice that observed at 2 x 10 -8 M. In Fig. l , where the specific activity of the l0 -s M peptide was 0.01 times that of the 2 x l0 -s M peptide, the receptor-mediated uptake of radiolabeled peptide at l0 -s M f-NleLeuPhe would be expected to amount to 2% of the counts taken up at 2 x 10 -8 M. In this experiment, the total counts taken up were approximately the same for cells in l0 -s M and 2 × l0 -8 M peptide. Thus 2% of the total uptake at l0 -s M appears to be via a receptor-mediated process and the remaining 98% must occur via the fluid phase.
Fluid uptake was also measured by the uptake of [~4C]sucrose (New England Nuclear) and [12SIlhemocyanin (Hy) (iodinated as described previously for bovine serum albumin [2] ). Hy degradation was monitored by precipitation with 10% trichloroacetic acid (TCA). To measure release of the cell-associated radioactivity, cells were incubated with [aH]f-NleLeuPhe or [~2Sl]Hy, washed, and were then returned to 37°C in HBSS for various times. The medium was removed and counted. The radioactivity remaining with the cells was also counted.
Peptide Digestion: Peptide digestion was assayed by partitioning into ethyl acetate. The aqueous medium containing released cell-associated radioactivity was brought to pH 2 with 1 N HC1, and an equal volume of ethyl acetate was added. After thorough mixing, the solution was allowed to separate into two phases. The intact f-NleLeuPhe, having a blocked amino group, partitions into ethyl acetate and the digestion products (any molecule with a free amino group will be protonated at pH 2) remain in the aqueous phase. The radioactivity (the s peptide is labeled with [ H]phenylalanine) in each of the phases was then counted. This analysis of peptide digestion was confirmed using thin layer chromatography. Hypertonic medium (regardless of solute used to increase the tonicity) had no effect on the partitioning assay.
Binding 5tudies: Each dish containing l0 T cells was incubated in 1.0 ml of HBSS (or the appropriate hypertonic solution) with l0 -7 M [3H]fNleLeuPhe at 4"C. After incubation, this medium was aspirated and the dish washed quickly (~6 s) and vigorously in two baths of 4"C saline of the appropriate tonicity. Cell-associated radioactivity was counted. In all experiments the dishes were monitored visually for cell loss.
Fluorescent Reagents:
The chemotactic peptide N-formyl-NleLeuPheNleTyrLys (hexapeptide) (Sigma Chemical Co.), was conjugated to tetramethylrhodamine isothiocyanate (TMR) (Research Organics Inc.) following the procedure of Niedel et al. (9) . Briefly, TMR (10 mM) was reacted with 2.5 mM hexapeptide in dry dimethylformamide containing 1% triethylamine for 18 h at 22"C. The product TMR-hexapeptide was purified by thin layer chromatography in chloroform, methanol, and triethylamine (5:2:1 by volume) (TMR-hexapeptide, Rf = 0.3; unconjugated hexapeptide, Rf = 0.15). Fluorescein isothiocyanate-Con A (FITC-Con A) (Sigma Chemical Co.) was used at a concentration of 500 #g/ml and FITC-dextran (Sigma Chemical Co.) was used at a concentration of 5 mg/ml.
Microscopy: Cells were viewed by phase-contrast and fluorescence microscopy equipped with SIT camera. Video output was recorded with a NEC video recorder. The images were photographed directly from the monitor.
Quin 2 Assay:
Human cells (2 x 107 cells/ml) in HBSS without phenol red containing 0.1% ovalbumin and 20 uM acetoxymethyl ester of quin 2 (Amersham Corp., Arlington Heights, IL) at pH 7.4 were incubated for 20 min in the dark at 37"C followed by a 20-min incubation at room temperature. The cells were washed twice and resuspended at 107 cells/ml in HBSS without phenol red containing 0.1% ovalbumin and kept on ice until used. For each assay l07 cells were pelleted and resuspended in 2 ml of medium of the appropriate tonicity prewarmed to 37"C. The cells were incubated at 37"C for 10 min before 10 -~ M n-formyl-MetLeuPhe was added. The changes in fluOrescence were measured in a stirred cuvette in a Perkin-Elmer spectrofluorometer (excitation at 339 nm and emission at 492 nm). Intracellular calcium concentration was calculated using the following equation: 
RESULTS
Hvpertonic Medium Inhibits Receptor-mediated But Not Fluid-Phase Uptake.
The chemotactic peptide, f-NleLeuPhe, is taken up by peritoneal PMNs in both a receptor-mediated and fluid-phase manner (13) . By varying the concentration of peptide, we can follow either receptor-mediated or fluid-phase uptake (see Materials and Methods). PMNs have a receptor for f-NleLeuPhe which has a dissociation constant,/G, of ~2 x 10 -8 M. At 2 x 10 -8 M, ~80% of the peptide uptake is saturable, i.e., can be competed for with a high concentration of unlabeled peptide. Thus, 80% of the uptake at 2 x l0 -8 M is via a receptor-mediated process. At 10 -5 M (1,000 times the/G), ~98% of the peptide uptake is accumulated via uptake of bulk fluid. We have used 2 x l0 -8 M f-NleLeuPhe as an indicator of receptor-mediated uptake and l0 -5 M f-NleLeuPhe as a fluid-phase marker. Placing the cells in hypertonic medium inhibited the receptor-mediated accumulation of f-NleLeuPhe without affecting the fluid-phase uptake of peptide (Fig. 1) . The persistence of fluid-phase uptake in hypertonic medium was confirmed using another fluid-phase marker, [~4C]sucrose. Cells in hypertonic medium accumulated the same amount of ['4C]sucrose as did control cells (Fig. 2) .
Morphological Examination of Effects of Hvpertonic Medium
To examine morphologically the effect of hypertonic medium on pinocytosis, we followed the uptake of the fluorescent 
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hexapeptide labeled with tetramethylrhodamine (TMR-hexapeptide). The hexapeptide has been shown to compete for the same receptor as f-NleLeuPhe (9). PMNs, exposed to 2 x 10 -9 M TMR-hexapeptide at 37"C, accumulated fluorescence within cytoplasmic organelles (both endocytic vesicles and phase-dense granules) which exhibited saltatory motion (Fig.  3, a and b) . The accumulation of fluorescence was due to receptor-mediated uptake since it could be competively inhibited by an excess of unlabeled f-NleLeuPhe (Fig. 3, c and d) . When PMNs were exposed to 2 x 10 -9 M TMR-hexapeptide in 0.75 osmolar medium (HBSS plus 0.225 M NaCl), the accumulation of fluorescence was dramatically inhibited (Fig.  3, e and f) . However, hypertonic medium had no effect on the accumulation of a fluorescent fluid-phase marker, FITCdextran (Fig. 3, g-j) . Similarly hypertonic medium had no effect on the accumulation of 10 -5 M TMR-hexapeptide. At this concentration, peptide accumulation occurs primarily in a fluid-phase manner. Thus, hypertonic medium inhibited the receptor-mediated internalization of peptide but did not prevent the formation of endosomes involved in the uptake of fluid markers.
Characterization of Inhibition
The extent of the inhibition of receptor-mediated uptake depended on the tonicity. Partial inhibition occurred in 0.45 and 0.6 osmolar medium, while maximal inhibition occurred in 0.75 osmolar medium (2.5 times normal tonicity) (Fig. 4) . The inhibition was independent of the solute used to increase the tonicity. Increasing the tonicity with sodium chloride, sucrose, or lactose inhibited uptake to a similar extent. The inhibition of receptor-mediated processes did not appear to occur at the level of receptor binding since incubation of cells 30 min in hypertonic medium at 37"C had little effect on subsequent peptide binding assayed at 4"C in hypertonic medium. In medium containing 0.45 M sucrose, the amount of saturably bound peptide at 2 x 10 -8 M was 1.24 _+ 0.33 times that bound to cells incubated in control HBSS (mean _+ SD, n = 8). With addition of 0.225 M NaCl to HBSS, the binding was 0.96 _+ 0.13 (n = 3) of control levels.
The inhibition was rapid; maximal inhibition of uptake occurred within 5 rain of placing cells in hypertonic medium. The effect was also rapidly reversible. Uptake returned to control levels within 5 min of returning the cells to isotonic medium, i.e., the slopes of the uptake curves were the same 5 min after return to control medium (Fig. 5) . The reversibility of the inhibition of hypertonic medium on the receptormediated accumulation was also followed morphologically. When PMNs were removed from hypertonic medium and placed in isotonic medium, they accumulated TMR-hexapeptide in a receptor-mediated manner.
Hvpertonic Medium Inhibits the Capping of
Con A
The fluorescent signal from the TMR-hexapeptide was too low to determine whether hypertonicity had any effect on the clustering of the peptide-receptor complex. Thus, to examine the effect of hypertonic medium on the aggregation and distribution of a cell surface marker, we followed the capping of Con A. Cells were incubated with FITC-Con A in control or hypertonic medium for 15 min at 37"C. While >80% of cells in control medium capped the FITC-Con A, <4% of the cells in hypertonic medium capped the FITC-Con A (Fig. FIGURE 3 Morphological examination of the effect of hypertonicity on receptor-mediated and fluid-phase endotycosis. PMNs were incubated for 30 min at 37°C with different fluorescent reagents in either HBSS or hNaCI. Living cells were viewed by phase-contrast microscopy (a, c, e, g, and i) or fluorescence microscopy (b, d, f, h, and j). To monitor receptor-mediated uptake, cells were incubated in HBSS with 2 x 10 -9 M TMR-hexapeptide (a and b). To document that the accumulation of the fluorescence observed in b was due to a saturable process, cells were incubated in HBSS with 2 x 10 -9 M TMR-hexapeptide plus 10 -5 M f-NleLeuPhe to compete for receptor binding (c and d). To evaluate receptor-mediated uptake in hypertonic medium, cells were incubated in 2 x 10 -9 M TMR-hexapeptide in hNaCI (e and f). To monitor fluid phase uptake, cells were incubated in FITC-dextran in HBSS (g and h) or in hNaCI (i and j). Table I ). The cells in hypertonic medium showed a diffuse pattern of fluorescence even after 60 min at 37"C. The inhibition of capping was reversible. Cells which had bound FITC-Con A in hypertonic NaC1 were pelleted and resuspended in HBSS in the absence of FITC-Con A. The F I T CCon A that was bound to the cells in hypertonic medium was now capped (Table I ). This result also demonstrates that the inability to visualize capping in hypertonic medium was not due to insufficient binding of FITC-Con A to the cell surface.
and
Characterization of Processing of Endocytosed Material in Hypertonic Medium
In Fig. 3 , we showed that hypertonic medium did not prevent the formation of endosomes containing fluid-phase markers. To assess whether there was any alteration of the intracellular fate of this endocytosed material, we examined the processing of this cell-associated material. After PMNs had accumulated peptide in a fluid-phase manner, peptide was removed and the cells were incubated in hypertonic medium at 37"C. As can be seen in Fig. 7a , hypertonic medium did not prevent the release of either intact or digested peptide. In fact, the proportion of f-NleLeuPhe released as digested peptide was slightly increased in hypertonic medium. We obtained similar results following the processing of another fluid-phase marker, [~25I]Hy. The uptake of [t2~I]Hy and the release of digested products (TCA-soluble radioactivity) and intact material (TCA-precipitable radioactivity) in hypertonic medium was similar to that seen in control cells (Fig. 8) . Thus, in hypertonic medium, endosomes containing fluid-phase markers appear to be processed normally.
Although hypertonic medium inhibited the continuing accumulation of peptide in a receptor-mediated manner, there was a small amount of peptide accumulation which reached a plateau within 5 min (Figs. 4 and 5) . Upon further incubation in the absence of peptide, the majority of this cellassociated peptide was released from the cells. The amount of intact peptide released from cells in hypertonic medium was 
TABLE I. Effect of Hypertonicity on Con A Capping
Cells capped after being washed and resuspended in Cells capped in 15 min HBSS for 15 min at Media at 37"C 37"C % % HBSS 84 _ 3.3; n ---3* 7 7 _ 7; n = 2 hNaCl* 3.7 + 5.3; n = 3 60 _ 9; n = 2 * n, the number of different experiments analyzed. 100 cells per sample were scored. The mean -_+ the standard deviation is given. hNaCI, HBSS plus 0.225 M NaCI.
the same as that seen in control cells (Fig. 7 b) . The kinetics of the uptake and release of the pool of intact peptide were similar to that seen in control cells. However, in contrast to that seen with fluid-phase markers, hypertonicity dramatically decreased the amount of digested peptide released. Thus, hypertonic medium prevented receptor-mediated peptide uptake and delivery of peptide into a compartment where digestion occurs but did not prevent the filling of a compartment from which peptide is subsequently released intact. Effect of Hypertonicity on Peptide-stimulated
Increase in Cytosolic Calcium
Chemotactic factors induce a rapid, transient increase in cytosolic calcium levels which can be measured with the fluorescent probe, quin 2 (10). We have asked whether addition of peptide would induce an increase in cytosolic calcium in cells in hypertonic medium . PMNs loaded with quin 2 in HBSS were switched to media of varying tonicities for 10 min at 37°C prior to peptide addition . Raising the osmolarity of the medium to 0.75 osmolar completely prevented the quin 2 signal upon addition of 10 -' M n-formyl-MetLeuPhe (Fig.  9) . The inhibition of the peptide-stimulation of quin 2 increased as the tonicity of the medium was increased and paralleled the inhibition of receptor-mediated uptake (Fig. 9 ).
DISCUSSION
We have found that hypertonic medium inhibited receptormediated but not fluid-phase endocytosis by PMNs. The effects of hypertonicity were documented biochemically and morphologically using Effect of increasing tonicity of peptide-stimulated increase in cytosolic calcium concentration . The fluorescent signal from quin 2 containing PMNs in media of varying tonicity was recorded both before and after addition of 10' M n-formyl-MetLeuPhe . The maximum stimulation of intracellular calcium concentration is plotted as a function of osmolarity . The tonicity of the medium was increased by the addition of NaCl to HBSS . Determination of intracellular calcium concentration is described in Materials and Methods .
back to the medium intact while most was digested and then released. Hypertonic medium prevented the receptor-mediated uptake and delivery of peptide into a compartment where digestion occurs but did not prevent the filling of a compartment from which peptide is subsequently released intact. The extent ofthe inhibition increased with increasing tonicity with maximal inhibition occurring at 0 .75 osmolar. The inhibition was independent of the solute used to increase the tonicity; sodium chloride, sucrose, and lactose all gave similar results. The inhibition was rapid and rapidly reversible . The reversibility of the effect and the persistence of fluid-phase uptake indicated that the inhibition was not due to nonspecific toxicity of the hypertonic medium.
Hypertonic medium appears to be unusual in its ability to rapidly and reversibly separate fluid-phase and receptor-mediated endocytosis by selectively inhibiting receptor-mediated uptake . Mostconditions reported to inhibit receptor-mediated uptake also inhibit fluid-phase uptake . Larkin et al . (6) found that depletion of intracellular potassium results in the inhibition of the receptor-mediated uptake of both low density lipoprotein and epidermal growth factor and the fluid-phase uptake of horseradish peroxidase in fibroblasts . This treatment also reduced the number of coated pits (6) . Kaplan and Keogh (5) have shown that in macrophages, the addition of amines decreased fluid-phase pinocytosis as well as the recep- To determine if hypertonic medium inhibited transduction of peptide-induced signals, we examined the peptide-stimulated increase in cytosolic calcium. This is an early response to peptide binding. Using the fluorescent calcium probe, quin 2, we found that incubating cells in 0.75 osmolar medium completely prevented the peptide-stimulated increase in cytosolic calcium levels. The extent of this inhibition showed a similar dependence on tonicity as that seen for the inhibition of receptor-mediated uptake. It is unknown whether the inhibition of Ca ++ mobilization and receptor-mediated uptake are due to the loss of a common intermediate coupling peptide-receptor binding to cellular responses. However, the similarity in the dose dependence of the two phenomena suggests this as a possibility.
Our data are consistent with the models pictured in Fig.  10 . In model A, hypertonicity prevents the internalization of surface receptor-bound peptide by preventing receptor clustering into forming endosomes. Fluid-phase material continues to be internalized and delivered to the digestion compartment. Unclustered receptors would only inefficiently facilitate ligand internalization. In support of this hypothesis, we have shown that hypertonic medium inhibits the surface aggregation of Con A.
In model B, hypertonic media allows receptor-ligand internalization but prevents their movement from a primary recycling endosome. In this model, both fluid-phase markers and peptide-receptor complexes are internalized in hypertonic medium into a reversible pinocytic compartment (recycling endosome pool). Fluid-phase material can be delivered to the lysosomal compartment where digestion occurs but the peptide-receptor complex remains in a reversible pinocytic compartment which is in steady-state with the cell surface. Mellman et al. (8) have presented a similar model to explain the recycling of the Fc receptor. They suggest that the state of the receptor aggregation may determine whether an internalized receptor remains in an endosome pool from which it can be recycled back to the cell surface or is removed from this pool and delivered to the lysosomes.
A third model would hypothesize two separate pathways of uptake; one for fluid-phase and a second for receptor-media-~' Receptor-ligand complex A Fluid-phase marker ted uptake. In this case, hypertonicity would selectively inhibit the pathway for receptor-mediated uptake.
Whichever model turns out to be right, the relationship between the binding and internalization of receptor-ligand complexes and the uptake of soluble markers is of interest in understanding the factors involved in the initiation of endocytosis as well as those factors important in the sorting of constituents within endosomal (pre-lysosomal) compartments. Hypertonic medium will be a useful tool with which to investigate the initial steps involved in the endocytic pathway.
